Index S&P 500
P/E 33.32
EPS (ttm) 3.21
Insider Own 0.73%
Shs Outstand 1.73B
Perf Week -1.67%
Market Cap 185.79B
Forward P/E 20.83
EPS next Y 5.14
Insider Trans -0.97%
Shs Float 1.72B
Perf Month -3.98%
Income 5.61B
PEG 4.27
EPS next Q 1.11
Inst Own 77.13%
Short Float 0.84%
Perf Quarter -6.24%
Sales 40.33B
P/S 4.61
EPS this Y 4.29%
Inst Trans 0.27%
Short Ratio 2.44
Perf Half Y 12.19%
Book/sh 22.26
P/B 4.81
EPS next Y 11.01%
ROA 7.72%
Short Interest 14.48M
Perf Year -2.97%
Cash/sh 4.19
P/C 25.52
EPS next 5Y 7.80%
ROE 15.15%
52W Range 89.67 - 121.64
Perf YTD -2.73%
Dividend Est. 2.12 (1.98%)
P/FCF 36.72
EPS past 5Y 19.65%
ROI 10.56%
52W High -11.98%
Beta 0.75
Dividend TTM 2.12 (1.98%)
Quick Ratio 1.16
Sales past 5Y 6.10%
Gross Margin 57.58%
52W Low 19.40%
ATR (14) 2.21
Dividend Ex-Date Apr 12, 2024
Current Ratio 1.64
EPS Y/Y TTM -16.61%
Oper. Margin 16.13%
RSI (14) 37.30
Volatility 2.51% 1.76%
Employees 114000
Debt/Eq 0.41
Sales Y/Y TTM -2.84%
Profit Margin 13.92%
Recom 1.81
Target Price 126.68
Option/Short Yes / Yes
LT Debt/Eq 0.38
EPS Q/Q -6.96%
Payout 63.81%
Rel Volume 0.83
Prev Close 107.28
Sales Surprise 0.82%
EPS Surprise 2.62%
Sales Q/Q 2.23%
Earnings Apr 17 BMO
Avg Volume 5.94M
Price 107.07
SMA20 -2.98%
SMA50 -6.20%
SMA200 0.36%
Trades
Volume 4,939,404
Change -0.20%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-21-23 Upgrade
Wolfe Research
Underperform → Peer Perform
May-30-23 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$112
Apr-20-23 Reiterated
Wolfe Research
Underperform
$107 → $103
Apr-20-23 Reiterated
UBS
Buy
$117 → $130
Apr-20-23 Reiterated
Raymond James
Outperform
$116 → $123
Apr-20-23 Reiterated
JP Morgan
Overweight
$118 → $122
Apr-20-23 Reiterated
Bernstein
Outperform
$132 → $133
Apr-20-23 Reiterated
Barclays
Overweight
$125 → $127
Mar-29-23 Initiated
UBS
Buy
$117
Oct-26-22 Initiated
Mizuho
Neutral
$105
Oct-18-22 Initiated
Barclays
Overweight
$118
Oct-12-22 Initiated
Jefferies
Hold
$110
Jul-06-22 Initiated
Wolfe Research
Underperform
$95
Mar-02-22 Resumed
BofA Securities
Buy
$140
Jan-27-22 Reiterated
UBS
Buy
$138 → $142
Jan-27-22 Reiterated
Raymond James
Outperform
$150 → $143
Jan-27-22 Reiterated
Morgan Stanley
Overweight
$157 → $151
Jan-27-22 Reiterated
Credit Suisse
Outperform
$138 → $139
Dec-10-21 Initiated
RBC Capital Mkts
Outperform
$146
Oct-27-21 Upgrade
Atlantic Equities
Neutral → Overweight
$144
Show Previous Ratings
Apr-22-24 09:00AM
Apr-19-24 09:44AM
07:53AM
07:37AM
Apr-18-24 10:55AM
08:41AM
Loading…
08:41AM
03:01AM
12:40AM
(Thomson Reuters StreetEvents)
Apr-17-24 04:11PM
(Investor's Business Daily)
04:06PM
(The Wall Street Journal)
02:31PM
(The Wall Street Journal)
01:59PM
01:30PM
12:55PM
(The Wall Street Journal)
11:52AM
10:42AM
Loading…
10:42AM
10:30AM
(Associated Press Finance)
10:19AM
(The Wall Street Journal)
10:13AM
10:02AM
09:54AM
09:30AM
08:51AM
08:40AM
08:00AM
07:58AM
07:52AM
(Investor's Business Daily)
07:46AM
07:36AM
(Associated Press Finance)
07:34AM
07:30AM
Loading…
07:30AM
06:15AM
(The Wall Street Journal)
Apr-16-24 05:04PM
Apr-15-24 11:42AM
Apr-14-24 09:30AM
Apr-13-24 12:18PM
Apr-12-24 09:51AM
09:15AM
08:00AM
(Investor's Business Daily)
Apr-11-24 07:02AM
06:15AM
Apr-09-24 05:50PM
Apr-08-24 01:50PM
10:10AM
09:00AM
Apr-05-24 09:52AM
09:30AM
Apr-03-24 08:00AM
Apr-02-24 04:11PM
11:18AM
09:36AM
09:23AM
09:07AM
09:00AM
Apr-01-24 06:00PM
09:00AM
Mar-31-24 04:34PM
Mar-27-24 04:30PM
12:25PM
Mar-26-24 06:00PM
09:00AM
08:02AM
07:45AM
06:18AM
06:07AM
05:15AM
Mar-25-24 12:58PM
09:15AM
Mar-24-24 10:42AM
Mar-22-24 04:25AM
12:33AM
Mar-21-24 10:25AM
Mar-20-24 05:50PM
08:11AM
08:00AM
Mar-19-24 06:00PM
01:40PM
09:30AM
08:49AM
08:00AM
Mar-18-24 09:50AM
Mar-17-24 08:50AM
Mar-15-24 10:37PM
04:34PM
04:10PM
(Investor's Business Daily)
03:34PM
09:00AM
08:30AM
Mar-14-24 11:02AM
Mar-12-24 05:50PM
08:31AM
06:00AM
Mar-11-24 07:03PM
06:00PM
10:10AM
05:35AM
Mar-07-24 12:27PM
05:00AM
Mar-06-24 04:15PM
(Investor's Business Daily)
02:47PM
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 963 114,116 125,697 Mar 04 07:18 PM ALLEN HUBERT L EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 853 101,080 184,806 Mar 04 06:39 PM Morrone Louis H. EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 801 94,918 62,968 Mar 04 07:14 PM Earnhardt Lisa D EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 694 82,239 84,314 Mar 04 06:50 PM Moreland Mary K EXECUTIVE VICE PRESIDENT Mar 01 '24 Sale 118.50 676 80,106 91,260 Mar 04 07:09 PM MCCOY JOHN A. JR. VICE PRESIDENT Mar 01 '24 Sale 118.50 472 55,932 18,760 Mar 04 07:05 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Feb 23 '24 Option Exercise 59.94 12,500 749,250 91,204 Feb 27 06:13 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Feb 23 '24 Sale 120.00 12,500 1,500,000 78,704 Feb 27 06:13 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Jan 29 '24 Option Exercise 50.80 42,500 2,158,950 90,027 Jan 31 05:30 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Jan 29 '24 Sale 112.50 42,500 4,781,250 65,027 Jan 31 05:30 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Dec 14 '23 Option Exercise 44.40 15,000 666,000 80,027 Dec 18 05:36 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Dec 14 '23 Sale 108.00 15,000 1,620,000 65,027 Dec 18 05:36 PM STARKS DANIEL J Director Oct 26 '23 Sale 94.05 50,000 4,702,526 6,725,316 Oct 30 04:58 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Aug 08 '23 Option Exercise 38.40 5,000 192,000 75,427 Aug 10 06:31 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT Aug 08 '23 Sale 105.03 10,400 1,092,297 65,027 Aug 10 06:31 PM STARKS DANIEL J Director Jul 27 '23 Sale 113.76 50,000 5,688,189 6,775,316 Jul 28 05:10 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT May 02 '23 Option Exercise 47.00 8,226 386,622 78,653 May 03 07:09 PM STARKS DANIEL J Director May 02 '23 Sale 111.02 50,000 5,551,193 6,825,316 May 02 08:04 PM Wainer Andrea F EXECUTIVE VICE PRESIDENT May 02 '23 Sale 110.56 8,226 909,472 70,427 May 03 07:09 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite